Sarepta Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

12:44	This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday (Benzinga)
03.11.25	Sarepta Therapeutics Stock Is Tumbling After The Close: Here's Why (Benzinga)
22.09.25	This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday (Benzinga)
15.09.25	Expert Outlook: Sarepta Therapeutics Through The Eyes Of 43 Analysts (Benzinga)
25.08.25	Forecasting The Future: 44 Analyst Projections For Sarepta Therapeutics (Benzinga)
07.08.25	What 43 Analyst Ratings Have To Say About Sarepta Therapeutics (Benzinga)
29.07.25	Sanmina, Sarepta Therapeutics, Polaris, Celestica And Other Big Stocks Moving Higher On Tuesday (Benzinga)
29.07.25	This Sarepta Therapeutics Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday (Benzinga)
29.07.25	Sarepta Therapeutics Surges Over 40% In Tuesday Pre-Market: What's Going On? (Benzinga)
29.07.25	BitMine Immersion, Sarepta Therapeutics, CEA Industries, Super Micro Computer And AMD: Why These 5 Stocks Are On Investors' Radars Today (Benzinga)
29.07.25	Sarepta Therapeutics Stock Soars After FDA Removes Hold On Elevidys For Some Patients (Benzinga)
24.07.25	This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday (Benzinga)
18.07.25	Sarepta Therapeutics Stock Plunges Over 30% In Friday Pre-Market: What's Going On (Benzinga)
17.07.25	Assessing Sarepta Therapeutics: Insights From 35 Financial Analysts (Benzinga)
17.07.25	Why Sarepta Therapeutics Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket (Benzinga)
16.07.25	Sarepta Therapeutics Stock Is Surging After The Bell: What's Going On? (Benzinga)
25.06.25	This Sarepta Therapeutics Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday (Benzinga)
25.06.25	Assessing Sarepta Therapeutics: Insights From 38 Financial Analysts (Benzinga)
20.06.25	This Sarepta Therapeutics Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday (Benzinga)
16.06.25	What the Options Market Tells Us About Sarepta Therapeutics (Benzinga)
16.06.25	This Sarepta Therapeutics Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday (Benzinga)
16.06.25	Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session (Benzinga)
16.06.25	Sarepta Therapeutics Stock Plummets Over 40% On Second Fatal Case Linked To Its Gene Therapy (Benzinga)
06.06.25	Sarepta Therapeutics Stock: A Deep Dive Into Analyst Perspectives (28 Ratings) (Benzinga)
20.05.25	Assessing Sarepta Therapeutics: Insights From 30 Financial Analysts (Benzinga)
07.05.25	Sarepta Therapeutics Stock Sinks On Gloomy Forecast, Analysts Expect Demand To Pick Up (Benzinga)
07.05.25	Sarepta Therapeutics Analysts Slash Their Forecasts After Q1 Results (Benzinga)
07.05.25	Sarepta Therapeutics, Mercury Systems, Arista Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session (Benzinga)
06.05.25	Sarepta Therapeutics Stock Plummets After Q1 Results: Here's Why (Benzinga)
03.04.25	Deep Dive Into Sarepta Therapeutics Stock: Analyst Perspectives (18 Ratings) (Benzinga)
18.03.25	12 Analysts Have This To Say About Sarepta Therapeutics (Benzinga)
18.03.25	S&P 500 Down 1%; Sarepta Therapeutics Shares Plunge (Benzinga)
18.03.25	Sarepta Therapeutics Reports Patient Death Post Elevidys Gene Therapy Treatment, Stock Plunges (Benzinga)
27.02.25	8 Analysts Have This To Say About Sarepta Therapeutics (Benzinga)
27.02.25	Sarepta Therapeutics (SRPT) Q4 2024 Earnings Call Transcript (MotleyFool)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	31.18	2.10 %	K V
Sika	152.55	2.04 %	K V
Swiss Re	149.75	1.56 %	K V
Holcim	71.20	1.42 %	K V
Givaudan	3’320.00	1.41 %	K V
Swiss Life Hldg	880.20	-0.18 %	K V
Lonza Grp	538.40	-0.30 %	K V
ABB	57.86	-0.48 %	K V
Swisscom	573.00	-0.69 %	K V
Alcon	59.84	-1.45 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Sarepta Therapeutics Aktie ISIN US0023461041

Nachrichten zu Sarepta Therapeutics Inc.

Aktien Top/Flop

Meistgelesene Nachrichten